Lipids in Health and Disease

Table 4 Univariate correlation between eGFR CKD-EPI and APOE, APOAI, and APOB concentrations, and apolipoprotein ratios

From: Apolipoprotein E gene polymorphism and renal function are associated with apolipoprotein E concentration in patients with chronic kidney disease

Parameter	Total		APOE subgroup
	Total		E2		E3		E4
	R	p	R	p	R	p	R	p
apoE	−0.11	0.32	0.68	0.002	−0.29	0.02	−0.37	0.19
apoE-HDL	−0.08	0.48	0.66	0.002	−0.15	0.27	−0.31	0.28
apoE-non-HDL	−0.08	0.47	0.57	0.01	−0.29	0.03	−0.25	0.38
apoE-IDL + LDL	0.09	0.39	0.78	< 0.001	−0.18	0.19	−0.18	0.54
apoE-VLDL	−0.26	0.02	−0.46	0.05	−0.19	0.15	−0.16	0.58
apoAI	0.10	0.34	0.64	0.004	−0.11	0.42	0.28	0.33
apoE-HDL/apoAI	−0.06	0.61	0.53	0.03	−0.11	0.43	−0.41	0.14
apoB	−0.20	0.06	0.05	0.83	−0.25	0.06	−0.38	0.18
apoB-IDL + LDL	−0.21	0.05	0.09	0.72	−0.28	0.04	−0.44	0.12
apoB-VLDL	−0.03	0.81	−0.10	0.69	0.07	0.61	0.13	0.67
apoE/apoB in non-HDL	0.15	0.18	0.56	0.01	−0.10	0.46	0.01	0.97
apoE/apoB in IDL + LDL	0.24	0.03	0.71	< 0.001	0.02	0.89	0.07	0.82
apoE/apoB in VLDL	−0.26	0.02	−0.34	0.17	−0.26	0.07	−0.17	0.56

APOE - apolipoprotein E, APOAI - apolipoprotein AI, APOB - apolipoprotein B, HDL - high density lipoprotein, VLDL - very low-density lipoprotein, IDL - intermediate density lipoprotein, LDL - low density lipoprotein
Subgroups: E2: ɛ2ɛ3 subjects; E3: ɛ3ɛ3 subjects; E4: ɛ3ɛ4 subjects

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com